Haofeng Lu
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 2
- Sphingolipid Metabolism and Signaling 1
- Surgery 3
- Co-authors
- Mi Li (3 shared papers)Tiequan Zhang (3 shared papers)Xiang Jiang (1 shared paper)Zhang Chen (1 shared paper)Hao Zhang (1 shared paper)Jie Liu (1 shared paper)Yufeng Yuan (1 shared paper)Xi Chen (1 shared paper)
- Journals
- Cellular and Molecular Biology (1 paper)International Journal of Surgery (1 paper)Medicine (1 paper)BMC Surgery (1 paper)BMC Cancer (1 paper)
- Partner nations
- China
In The Last Decade
Haofeng Lu
7 papers receiving 203 citations
Haofeng Lu's Hit Papers
Peers
Comparison fields: 5 of 34
- Hepatology 53
- Cancer Research 94
- Molecular Biology 127
- Oncology 29
- Pathology and Forensic Medicine 19
Countries citing papers authored by Haofeng Lu
This map shows the geographic impact of Haofeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haofeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haofeng Lu more than expected).
Fields of papers citing papers by Haofeng Lu
This network shows the impact of papers produced by Haofeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haofeng Lu. The network helps show where Haofeng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Haofeng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | METTL5 stabilizes c‐Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression Hit paper breakdown → | 2023 | 99 |
| 2 | 2015 | 48 | |
| 3 | 2021 | 31 | |
| 4 | 2020 | 16 | |
| 5 | 2021 | 4 | |
| 6 | 2020 | 4 | |
| 7 | 2022 | 3 | |
| 8 | 2025 | 0 | |
| 9 | 2025 | 0 |
About Haofeng Lu
Haofeng Lu is a scholar working on Molecular Biology, Surgery, Cancer Research, Oncology and Epidemiology, having authored 9 papers that have together received 205 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), RNA modifications and cancer (2 papers), Colorectal Cancer Surgical Treatments (1 paper), MicroRNA in disease regulation (1 paper), Pituitary Gland Disorders and Treatments (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), Sphingolipid Metabolism and Signaling (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Hepatology (53 citations), Cancer Research (94 citations), Molecular Biology (127 citations), Oncology (29 citations) and Pathology and Forensic Medicine (19 citations). Haofeng Lu has collaborated with scholars based in China. Frequent co-authors include Mi Li, Tiequan Zhang, Xiang Jiang, Zhang Chen, Hao Zhang, Jie Liu, Yufeng Yuan, Xi Chen, Peng Xia and Zhonglin Zhang. Their work appears in journals such as Cellular and Molecular Biology, International Journal of Surgery, Medicine, BMC Surgery and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.